Terazosin Capsule
Product Images NDC 71335-3059

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Terazosin (NDC 71335-3059). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Figure 01)

This text provides data on the mean change in total symptom score and mean increase in peak flow rate from baseline in a study comparing the effects of placebo and terazosin. The study involved 54 participants, and the results are presented in Figure 1. The information seems to be part of clinical trial findings for evaluating the effectiveness of terazosin compared to placebo.*

FDA Label Image

Image Description (Figure 02)

This text provides a summary of the mean change in the total symptom score from baseline in a long-term, open-label, non-placebo controlled study involving 494 participants. The changes in the score are shown over a period of 30 months.*

FDA Label Image

Image Description (Figure 03)

This text provides data on the mean change in peak flow rate from baseline in a long-term, open-label, non-placebo controlled study involving 494 participants. The graph shows the mean change in peak flow rate in mL/sec over a period of 30 months, with data points at various intervals from 0 to 30 months.*

FDA Label Image

Label (Lbl713353059)

The text indicates the description of a medication containing Hydrochloride equivalent to terazosin 2 mg per capsule. The recommended usual dosage and additional details about storage conditions are provided. The capsule is mentioned to be dispensed in a tight, light-resistant container and stored at a temperature range of 20° to 25°C (68° to 77°F). The packaging includes a QR code for full prescribing information. The product is manufactured by Bryant Ranch Prepack, Inc. and repackaged by OrBion. It is advised to protect the capsules from light and moisture.*

FDA Label Image

Image Description (Structure001)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.